Kenneth Zuerblis

Kenneth Zuerblis is a board member at Stemline Therapeutics. Kenneth has also served as the Chief Financial Officer, Senior Vice President and Treasurer at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. In addition, they have held executive positions at Enzon Pharmaceuticals, Stemline Therapeutics Inc, Zenith Epigenetics and Resverlogix Inc.

Kenneth Zuerblis began their career in 1981 as a senior manager at KPMG US. Kenneth left KPMG in 1988 to become an adjunct professor of accounting at Montclair State University. Kenneth returned to the corporate world in 1991 when they became executive vice president, chief financial officer and treasurer at Enzon Pharmaceuticals. Kenneth held this position until 2005 when they left to join ImClone Systems. Kenneth remained with ImClone until 2009 before moving on to their current role at Stemline Therapeutics.

Kenneth Zuerblis received their Bachelor of Science in Accounting and Finance from Seton Hall University. Kenneth also attended Parsippany Hills High School. Kenneth is certified as a public accountant by the State of New Jersey.